{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:25:28Z","timestamp":1787682328907,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.neuropharm.2010.08.011","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T05:07:29Z","timestamp":1282194449000},"page":"612-618","source":"Crossref","is-referenced-by-count":57,"title":["Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure"],"prefix":"10.1016","volume":"59","author":[{"given":"Bradford D.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul V.","family":"Edwankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Furtm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Ramerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Sieghart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samarpan","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.08.011_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.089920","article-title":"TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-30ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for \u03b12 and \u03b13-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates","volume":"316","author":"Atack","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0026-895X(25)08999-0","article-title":"Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors","volume":"42","author":"Choudhary","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib2","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib3","series-title":"The Benzodiazepines","first-page":"327","article-title":"Effects of behaviorally active drugs in a conflict-punishment procedure in rats","author":"Cook","year":"1973"},{"key":"10.1016\/j.neuropharm.2010.08.011_bib4","unstructured":"Cook, J.M., Zhou, H., Huang, S., Srirama Sarma, P.V.V., Zhang, C., 2009. Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects, US Patent 7,618,958 B2, Issued November 17, 2009."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib5","unstructured":"Cook, J.M., Edwankar, R., Edwankar, C., Huang, S., Jain, H., Rivas, F., Yang, J., Zhou, H., 2010. Selective anticonvulsant agents and their uses, T08025US Utility, Serial # 12\/725,763, Filed March 17, 2010."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib6","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2008.01.015","article-title":"Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates","volume":"90","author":"Dixon","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00429273","article-title":"The effects of meprobamate, barbiturate, damphetamine and promazine on experimentally-induced conflict in the rat","volume":"1","author":"Geller","year":"1960","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2010.08.011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","article-title":"Benzodiazepine self-administration in humans and laboratory animals\u2013implications for problems of long-term use and abuse","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s002130051024","article-title":"Effects of different classes of partial benzodiazepine agonists on punished and unpunished responding in pigeons","volume":"144","author":"Kleven","year":"1999","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/jpet.104.081612","article-title":"Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]","volume":"313","author":"Licata","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.08.011_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1092852900009901","article-title":"Overview of diagnosis and drug treatments of anxiety disorders","volume":"10","author":"Nutt","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib18","series-title":"Current Protocols in Neuroscience","article-title":"Intravenous self-administration techniques in monkeys","author":"Platt","year":"2005"},{"key":"10.1016\/j.neuropharm.2010.08.011_bib19","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.2551039","article-title":"Type I and type II GABAA-benzodiazepine receptors produced in transfected cells","volume":"245","author":"Pritchett","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.08.011_bib20","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/jm801652d","article-title":"Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models","volume":"52","author":"Rivas","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00213-005-0228-8","article-title":"Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors","volume":"184","author":"Rowlett","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.08.011_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.08.011_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0165-6147(00)01646-1","article-title":"GABA(A) receptor subtypes: dissecting their pharmacological functions","volume":"22","author":"Rudolph","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2008.02.020","article-title":"PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats","volume":"1208","author":"Savi\u0107","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.08.011_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3565(25)31659-9","article-title":"Comparison of drug effects on responding punished by pressurized air or electric shock delivery in squirrel monkeys: pentobarbital, chlordiazepoxide, d-amphetamine and cocaine","volume":"209","author":"Spealman","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:05:11Z","timestamp":1740409511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0028390810002108"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.08.011","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}